,52 Given the absence of approved pharmacological therapy for AAA, the linear association with no evident threshold effect, and the comparative risk profile to CAD at higher concentrations, Lp(a)-targeted therapy may be a viable for the prevention of AAA. Here, LPA is linked to triple-A syndrome.